Skip to main navigation Skip to search Skip to main content

Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer

Pedro T. Ramirez, Charles N. Landen, Robert L. Coleman, Michael R. Milam, Charles Levenback, Taren A. Johnston, David M. Gershenson

Research output: Contribution to journal › Article › peer-review

35   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry